Cabergoline and dyspnoea Patient Reports February 12, 2012

Cabergoline Side Effects Report #6004852-3
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on Dec 04, 2008. Female patient was diagnosed with prolactinoma and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: acute myocardial infarction, cardiac aneurysm, cardiac valve disease, dyspnoea, mitral valve incompetence, ventricular tachycardia. Cabergoline dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID, ATENOLOL, ACETAMINOPHEN W, CREON, DOMPERIDONE, ENALAPRIL MALEATE, FERROUS SULPHATE, FLUOXETINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4597248-2
Cabergoline side effect was reported by a Physician from on Feb 16, 2005. Male patient, 85 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: asthenia, cardiac disorder, cardiac failure, dyspnoea, pericardial effusion. Cabergoline dosage: unknown. During the same period patient was treated with MADOPAR, DICLOFENAC, SPIRONOLACTONE, TORADEMIDE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4603279-6
Cabergoline side effect was reported by a Physician from on Feb 23, 2005. Male patient, 85 years of age, weighting 152.1 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: asthenia, cardiac failure, dyspnoea, pericardial effusion. Cabergoline dosage: 4 + 6MG (4 MG) ORAL. During the same period patient was treated with MADOPAR, DICLOFENAC, SPIRONOLACTONE, TORSEMIDE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #5637425-2
Cabergoline side effect was reported by a Physician from JAPAN on Feb 13, 2008. Female patient, 80 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: dyspnoea, parkinson's disease , pleural effusion. Cabergoline dosage: unknown. Patient recovered.


Cabergoline Side Effects Report #5608635-5
Cabergoline side effect was reported by a Consumer or non-health professional from GERMANY on Jan 20, 2008. Female patient, 75 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac arrest , cardiogenic shock, chest pain , dyspnoea, hypotension, mitral valve incompetence, mitral valve sclerosis. Cabergoline dosage: DAILY DOSE:4MG. Patient was hospitalized. Patient died.

Cabergoline Side Effects Report #5085990-9
Cabergoline side effect was reported by a Physician from JAPAN on Aug 02, 2006. Female patient, 74 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, condition aggravated, disseminated intravascular coagulation, dyspnoea, mitral valve incompetence, oedema peripheral, pulmonary hypertension , pulmonary oedema, tricuspid valve incompetence. Cabergoline dosage: 4 MG (4 MG, 1 IN 1 D), ORAL. During the same period patient was treated with LEVODOPA. Patient was hospitalized. Patient died.

Cabergoline Side Effects Report #5094396-8
Cabergoline side effect was reported by a Physician from DENMARK on Aug 16, 2006. Male patient, 73 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, dyspnoea, mitral valve incompetence, mitral valve sclerosis, pleural fibrosis. Cabergoline dosage: 6 MG (DAILY), ORAL. During the same period patient was treated with CORODIL, COMTESS, SINEMET. Patient recovered.

Cabergoline Side Effects Report #4688270-6
Cabergoline side effect was reported by a Physician from on May 27, 2005. Male patient, 73 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, cardiac valve disease, dyspnoea, fibrosis, mitral valve incompetence, mitral valve sclerosis, pleural fibrosis. Cabergoline dosage: 6 MG (DAILY), ORAL. During the same period patient was treated with CORODIL, COMTESS, SINEMET. Patient recovered.

Cabergoline Side Effects Report #5414313-8
Cabergoline side effect was reported by a Physician from JAPAN on Aug 02, 2007. Female patient, 72 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, dyspnoea, oedema peripheral, palpitations. Cabergoline dosage: unknown. During the same period patient was treated with DOPASTON, TOLEDOMIN, THYRADIN S. Patient recovered.


Cabergoline Side Effects Report #4803616-3
Cabergoline side effect was reported by a Health Professional from AUSTRALIA on Sept 12, 2005. Male patient, 72 years of age, weighting 176.4 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: chest pain , dyspnoea, pleural effusion. Cabergoline dosage: 4 MG (4 MG, QD). During the same period patient was treated with SINEMET, FLORINEF, WARFARIN. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4911029-9
Cabergoline side effect was reported by a Health Professional from AUSTRALIA on Feb 01, 2006. Male patient, 72 years of age, weighting 176.4 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: chest pain , dyspnoea, pleural effusion. Cabergoline dosage: 4 MG (4 MG, DAILY). During the same period patient was treated with SINEMET, FLORINEF, WARFARIN. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4585594-8
Cabergoline side effect was reported by a Physician from on Jan 31, 2005. Male patient, 71 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: dyspnoea, pleural adhesion. Cabergoline dosage: 2 MG (2 MG, 1 IN 1D), ORAL. During the same period patient was treated with MADOPAR, SELEGILINE HYDROCHLORIDE. Patient recovered.

Cabergoline Side Effects Report #4614167-3
Cabergoline side effect was reported by a Physician from on Mar 03, 2005. Female patient, 68 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cough, dyspnoea, interstitial lung disease, pleural effusion. Cabergoline dosage: 3 MG (1 MG, 1 IN 3 D), ORAL. During the same period patient was treated with MADOPAR, TALIPEXOLE HYDROCHLORIDE, AMANTADINE, SELEGILINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4615374-6
Cabergoline side effect was reported by a Physician from on Mar 04, 2005. Male patient, 68 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: dyspnoea, pleural effusion, pleural fibrosis. Cabergoline dosage: 4 MG. Patient recovered.


Cabergoline Side Effects Report #4629445-1
Cabergoline side effect was reported by a Physician from on Mar 23, 2005. Male patient, 68 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: condition aggravated, dyspnoea, parkinson's disease , pleural effusion, pleural fibrosis. Cabergoline dosage: 4 MG (4 MG, DAILY), ORAL. During the same period patient was treated with MADOPAR. Patient recovered.

Cabergoline Side Effects Report #4753569-1
Cabergoline side effect was reported by a Physician from GERMANY on Aug 15, 2005. Female patient, 67 years of age, weighting 121.3 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: anaemia, aortic valve incompetence, atrial flutter, dyspnoea, dyspnoea at rest, dyspnoea exertional, inflammation, pericarditis constrictive, pleural effusion. Cabergoline dosage: unknown. During the same period patient was treated with MADOPAR, COMTESS, AMANTADINE, NACOM, EDRONAX. Patient was hospitalized and became disabled. Patient recovered.

Cabergoline Side Effects Report #4577451-8
Cabergoline side effect was reported by a Physician from on Jan 26, 2005. Male patient, 66 years of age, weighting 121.3 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, dizziness , dyspnoea, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 6 MG (2 MG, ) , ORAL. During the same period patient was treated with MADOPAR, ENTACAPNE. Patient recovered.

Cabergoline Side Effects Report #4757117-1
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on Aug 17, 2005. Female patient, 65 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, dyspnoea. Cabergoline dosage: (5 MG), ORAL. During the same period patient was treated with SINEMET, AMANTADINE, NAPROXEN. Patient recovered.

Cabergoline Side Effects Report #4757114-6
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on Aug 17, 2005. Male patient, 62 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve stenosis, dyspnoea. Cabergoline dosage: (3 MG), ORAL. During the same period patient was treated with PERGOLIDE, SINEMET, AMANTADINE. Patient recovered.


Cabergoline Side Effects Report #4765472-1
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on Aug 25, 2005. Male patient, 62 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve stenosis, dyspnoea. Cabergoline dosage: (3 MG), ORAL. During the same period patient was treated with PERGOLIDE, SINEMET, AMANTADINE. Patient recovered.

Cabergoline Side Effects Report #4767672-3
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on Sept 01, 2005. Male patient, 62 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve stenosis, dyspnoea. Cabergoline dosage: (3 MG,), ORAL. During the same period patient was treated with PERGOLIDE, SINEMET, AMANTADINE. Patient recovered.

Cabergoline Side Effects Report #5102783-4
Cabergoline side effect was reported by a Consumer or non-health professional from DENMARK on Aug 28, 2006. Male patient, 56 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cough, dyspnoea, emphysema, increased upper airway secretion, interstitial lung disease, pleurisy, pulmonary fibrosis , pulmonary function test decreased. Cabergoline dosage: unknown. During the same period patient was treated with ELDEPRYL, REQUIP, SINEMET, COMTESS, SIFROL. Patient recovered.

Cabergoline Side Effects Report #5605335-2
Cabergoline side effect was reported by a Physician from AUSTRALIA on Jan 17, 2008. Male patient, 48 years of age, weighting 132.3 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: crepitations, dyspnoea, hypoxia, pleural fibrosis. Cabergoline dosage: unknown. During the same period patient was treated with LEVODOPA, COMTAN. Patient was hospitalized and became disabled. Patient recovered.

Cabergoline Side Effects Report #5104134-8
Cabergoline side effect was reported by a Consumer or non-health professional from DENMARK on Aug 28, 2006. Female patient, 41 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, dyspnoea, mitral valve incompetence, mitral valve stenosis, obstruction, obstructive airways disorder, total lung capacity decreased. Cabergoline dosage: 4 MG (DAILY), ORAL. During the same period patient was treated with MADOPAR. Patient recovered.


Cabergoline Side Effects Report #5150533-8
Cabergoline side effect was reported by a Consumer or non-health professional from SWEDEN on Oct 26, 2006. Female patient, 35 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cough, dyspnoea, pleural fibrosis. Cabergoline dosage: unknown. Patient recovered.

Cabergoline Side Effects Report #5121323-7
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on Sept 20, 2006. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: dyspnoea, gastrointestinal carcinoma, metastases to lung. Cabergoline dosage: 2.5 MG, ORAL. During the same period patient was treated with CODEINE PHOSPHATE, PROCYCLIDINE HYDROCHLORIDE, OMEPRAZOLE, DEXAMETHASONE, ATENOLOL, BENDROFLUMETHIAZIDE. Patient was hospitalized. Patient died on 09/03/2006.

Cabergoline Side Effects Report #6025156-9
Cabergoline side effect was reported by a Consumer or non-health professional from GERMANY on Dec 16, 2008. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: alopecia, aortic valve incompetence, arrhythmia , delusion, dyspnoea, fatigue, hypertension, mitral valve incompetence, oedema peripheral. Cabergoline dosage: 4MG PER DAY. During the same period patient was treated with NACOM. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4565809-2
Cabergoline side effect was reported by a Physician from on Jan 17, 2005. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cough, dyspnoea, mitral valve incompetence, oedema. Cabergoline dosage: 8 MG, ORAL. During the same period patient was treated with ESTROGENS, MADOPAR. Patient recovered.

Cabergoline Side Effects Report #4575789-1
Cabergoline side effect was reported by a Physician from on Jan 24, 2005. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, blood pressure increased, dyspnoea, dyspnoea exertional, face oedema, histology abnormal, mitral valve disease, mitral valve incompetence, mitral valve prolapse. Cabergoline dosage: 8 MG, ORAL. During the same period patient was treated with ESTROGENS, MADOPAR, ACETYLSALICYLIC ACID SRT, ZUMESTON. Patient recovered.


Cabergoline Side Effects Report #4613211-7
Cabergoline side effect was reported by a Pharmacist from on Mar 02, 2005. Male patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: dyspnoea, fall . Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4648761-0
Cabergoline side effect was reported by a Physician from on Apr 14, 2005. Male patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: dyspnoea, lung infiltration, pleural effusion, tuberculosis . Cabergoline dosage: 2 MG (2 MG, 1 IN 1 D); ORAL. During the same period patient was treated with SINEMET. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4690036-8
Cabergoline side effect was reported by a Physician from on May 31, 2005. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: dyspnoea, heart valve insufficiency, pericarditis constrictive, pleural effusion. Cabergoline dosage: 8 MG (8 MG, DIALY), ORAL. During the same period patient was treated with MADOPAR, COMTESS, AMANTADINE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4710538-5
Cabergoline side effect was reported by a Physician from GERMANY on June 27, 2005. Female patient, weighting 132.3 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, cardiac output decreased, coronary artery atherosclerosis, dyspnoea, mitral valve disease, mitral valve incompetence, mitral valve sclerosis, pleural effusion. Cabergoline dosage: DAILY, ORAL ; 6 MG (DAILY) ORAL. During the same period patient was treated with SELEGILINE, TEBONIN, NEUROPLANT, BISOPROLOL FUMARATE, GINGIUM, FUROSEMIDE, HEPARIN. Patient was hospitalized and became disabled. Patient recovered.

Cabergoline Side Effects Report #5100675-8
Cabergoline side effect was reported by a Consumer or non-health professional from DENMARK on Aug 24, 2006. Female patient, 60 years of age, was treated with Cabergoline. After drug was administered, patient experienced the following side effects: bradycardia, cardiac procedure complication, chest discomfort, dyspnoea, electrocardiogram abnormal, heart rate irregular, mitral valve incompetence, mitral valve stenosis. Cabergoline dosage: 10 MG DAILY, ORAL. During the same period patient was treated with GABAPENTIN, SINEMET, PAMOL, MANDOLGIN, REQUIP, CENTYL MITE W, PERMAX, SIFROL. Patient was hospitalized. Patient recovered.


Cabergoline Side Effects Report #5218471-X
Cabergoline side effect was reported by a Physician from GERMANY on Jan 04, 2007. Female patient was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, arrhythmia , cardiac valve disease, chest pain , dyspnoea, mitral valve incompetence, oedema, syncope, tricuspid valve incompetence. Cabergoline dosage: unknown. Patient recovered.